KRT19 and non-small cell lung carcinoma: In NSCLC, the mRNA expression of cytokeratin 19 (CK19) is the most well-studied marker for CTCs; in this context, our group has previously demonstrated the clinical value of the detection and monitoring of CK19mRNA+ CTCs in locally advanced or metastatic NSCLC [18].